Should we avoid heart transplantation in cardiomyopathy due to radiotherapy/chemotherapy or amyloidosis? the devil is in the details

Journal of Heart and Lung Transplantation

Volumn 31, Issue 12, 2012, Pages 1253-1256

  Nohria, Anju ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; PROTEIN TYROSINE KINASE INHIBITOR; TRASTUZUMAB;

AMYLOIDOSIS INDUCED CARDIOMYOPATHY; CARDIOTOXICITY; CHEMOTHERAPY INDUCED CARDIOMYOPATHY; HEART OUTPUT; HEART TRANSPLANTATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MORTALITY; NOTE; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; RADIOTHERAPY INDUCED CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84870489913     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2012.10.014     Document Type: Editorial

References (24)

1. M.S. Maron, B.M. Kalsmith, J.E. Udelson, W. Li, and D. DeNofrio Survival after cardiac transplantation in patients with hypertrophic cardiomyopathy Circulation 3 2012 574 579
2. E. DePasquale, K. Nasir, and D. Jacoby Outcomes of adults with restrictive cardiomyopathy post heart transplantation J Heart Lung Transplant 31 2012 1269 1275
3. T.P. Singh, C.S. Almond, G. Piercey, and K. Gauvreau Current outcomes in US children with cardiomyopathy listed for heart transplantation Circulation 5 2012 594 601
4. S.D. Zangwill, D. Naftel, and T. L'Ecuyer Outcomes of children with restrictive cardiomyopathy listed for heart transplant: a multi-institutional study J Heart Lung Transplant 28 2009 1335 1340
5. P. Richardson, W. McKenna, and M. Bristow Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies Circulation 93 1996 841 842
6. S.A. Webber, and S.E. Lipshultz Sleeper LA, et al. Outcomes of restrictive cardiomyopathy in childhood and the influence of phenotype: a report from the pediatric cardiomyopathy registry Circulation 126 2012 1237 1244
7. B.R. Dey, S.S. Chung, and T.R. Spitzer Cardiac transplantation followed by dose-intensive melphalan and autologous stem-cell transplantation for light chain amyloidosis and heart failure Transplantation 90 2012 905 911
8. T.S. Kato, H. Takayama, and S. Yoshizawa Cardiac transplantation in patients with hypertrophic cardiomyopathy Am J Cardiol 110 2012 568 574
9. S.W. Dubrey, M.M. Burke, P.N. Hawkins, and N.R. Banner Cardiac transplantation for amyloid heart disease: the United Kingdom experience J Heart Lung Transplant 23 2004 1142 1153
10. E. Roig, L. Almenar, F. Gonzalez-Vilchez, and G. Rabago Outcomes of heart transplantation for cardiac amyloidosis: subanalysis of the Spanish registry for heart transplantation Am J Transplant 9 2009 1414 1419
11. J. Kpodonu, M.G. Massad, A. Caines, and A.S. Geha Outcome of heart transplantation in patients with amyloid cardiomyopathy J Heart Lung Transplant 24 2005 1763 1765
12. M.Q. Lacy, A. Dispenzieri, and S.R. Hayman Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathy J Heart Lung Transplant 27 2008 823 829
13. B.C. Varr, M. Liedtke, S. Arai, R.A. Lafayette, S.L. Schrier, and R.M. Witteles Heart transplantation and cardiac amyloidosis: approach to screening and novel management strategies J Heart Lung Transplant 31 2012 325 331
14. M. Tukenova, C. Guibout, and O. Oberlin Role of cancer treatment in long-term overall and cardiovascular mortality after childhood cancer J Clin Oncol 28 2010 1308 1315
15. A. Albini, G. Pennesi, F. Donatelli, R. Cammarota, S. De Flora, and D.M. Noonan Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention J Natl Cancer Inst 102 2012 14 25
16. D.A. Mulrooney, M.W. Yeazel, and T. Kawashima Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort BMJ 339 2009 b4606
17. K.M. Ward, H. Binns, C. Chin, and S.A. Webber Canter CE, Pahl E. Pediatric heart transplantation for anthracycline cardiomyopathy: cancer recurrence is rare J Heart Lung Transplant 23 2004 1040 1045
18. G. Levitt, A. Anazodo, M. Burch, and K. Bunch Cardiac or cardiopulmonary transplantation in childhood cancer survivors: an increasing need? Eur J Cancer 45 2009 3027 3034
19. G.H. Oliveira, B.W. Hardaway, A.Y. Kucheryavaya, J. Stehlik, L.B. Edwards, and D.O. Taylor Characteristics and survival of patients with chemotherapy-induced cardiomyopathy undergoing heart transplantation J Heart Lung Transplant 31 2012 805 810
20. N. Uriel, A. Vainrib, and U.P. Jorde Mediastinal radiation and adverse outcomes after heart transplantation J Heart Lung Transplant 29 2012 378 381
21. M.C. Hull, C.G. Morris, C.J. Pepine, and N.P. Mendenhall Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy JAMA 290 2003 2831 2837
22. S.G. Drakos, A.G. Kfoury, and E.M. Gilbert Multivariate predictors of heart transplantation outcomes in the era of chronic mechanical circulatory support Ann Thorac Surg 83 2007 62 67
23. K.C. Oeffinger, A.C. Mertens, and C.A. Sklar Chronic health conditions in adult survivors of childhood cancer N Engl J Med 355 2006 1572 1582
24. A.S. Chang, N.G. Smedira, and C.L. Chang Cardiac surgery after mediastinal radiation: extent of exposure influences outcome J Thorac Cardiovasc Surg 133 2007 404 413